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Regarding surgery for malignant brain tumors, it is agreed upon by most 
neurosurgeons and supported by strong evidence that gross-total resections (GTRs) 
are associated with longer survival. One of the main challenges in achieving the 
largest extend of resection without causing damage to the surrounding healthy brain 
parenchyma is the distinction between tumor and normal brain. This distinction is 
especially difficult in primary brain tumors, which often show a diffuse growth pattern 
resulting in a transitional zone at the tumor margins where malignant and normal 
cells are intermingled. In cases where visual identification of tumor is not possible, 
intraoperative frozen sections are the current gold standard. However, they are time-
consuming (20-40min) and therefore cannot be repeated as often as one might 
require this information. In addition, the results are often unspecific or inconclusive. 
Therefore, much effort has been invested in the development of technologies that 
might improve the extent of tumor resection. In daily practice, neurophysiological 
monitoring, neuronavigation, intraoperative magnetic resonance imaging (ioMRI), 
intraoperative ultrasound (ioUS) and 5-aminolevulinic acid (5-ALA) are the most 
frequently used ones. 
Recently, a new technique called rapid evaporative ionization mass spectrometry 
(REIMS) has been put forward by Balog et al. [2]. The authors analyzed the “smoke” 
created by electrosurgery (either monopolar or bipolar) by means of REIMS. They 
coined the term “intelligent knife” (iKnife) for this coupling of electrosurgery and mass 
spectrometry which allows near-real-time characterization of human tissue. In a first 
step, Balog et al. analyzed 302 different human tissue samples in the laboratory, 
resulting in a database of tissue-specific mass spectra with 1624 cancerous and 
1309 noncancerous entries. Afterwards, the technology was translated into the 
operative theater and mass spectra from 81 surgical resections were analyzed. This 
study represents the first-in-human application of this novel technology. The results 
of both the ex vivo and the in vivo analyses are convincing. Out of the 2933 database 
entries derived from ex vivo experiments, a total of 254 spectra originated from brain 
tissue (49 spectra from 6 glioblastoma samples, 99 spectra from 10 metastases, 87 
spectra from other brain tumors, and 19 spectra from healthy grey or white matter). 
Leave-one-patient-out cross-validation was used and shows high rates for 
glioblastomas (83.7%) and metastases (92.3%); the rate of incorrectly classified 
tumor specimens as healthy tissue was 2.0% for glioblastoma and 7.7% for 
metastases.  
Regarding the intraoperative (in vivo) analysis of surgical specimen, the authors 
analyzed a total of 864 spectra acquired from 81 patients. When compared to the 
postoperative histopathological diagnosis, the overall sensitivity was 97.7% and the 
specificity was 96.5% (classification cancer vs. healthy). Neurosurgical specimen (11 
brain tumors, not specified further by the authors) were detected with a sensitivity 
and specificity of 100%. The procedure of sampling the smoke, transfer to the mass 
spectrometer, analysis and feedback to the surgeon took 0.7 to 2.5 seconds. When 
compared to frozen sections (20-40min) this new technology does allow frequent 
testing and potentially shortens the entire surgery duration.  
Despite discriminating between tumor and healthy tissue, REIMS was also 
successful in differentiating different grades of a tumor (such as WHO grades of brain 
tumors) as well as in differentiating metastases from distinct primary tumors. 
Balog et al. used REIMS coupled to a monopolar as well as to a bipolar 
electrosurgery device. It seems clear that the bipolar setup is the one that is relevant 
to the neurosurgeon. 
During tumor resections in neurosurgery an alternative to electrosurgery, ultrasonic 
disintegration and aspiration of tumor tissue, is frequently used. This mode of tumor 
resection does not produce any smoke than can be analyzed. However, an off-line 
method using frozen material from the effluent of the ultrasonic aspiration device for 
desorption electrospray ionization mass spectrometry (DESI-MS) has been 
suggested in a proof-of-concept study [1] and another group was able to perform 
real-time analyses during ultrasonic aspiration by coupling a cavitron ultrasonic 
surgical aspirator (CUSA) to a Venturi easy ambient sonic – spray ionization (V-
EASI) system [3]. However, the results of the latter setup are only presented for ex 
vivo experiments and specific results for sensitivity and specificity are not given.  
In our opinion, the in vivo tested and highly sensitive and specific method REIMS 
could be combined with surgical aspirators (even with those that do not use 
ultrasonic tissue disintegration) by adding a bipolar electrosurgery device to the tip of 
the aspirator that can be advanced by the surgeon (see Figure 1). The smoke 
produced during bipolar electrocautery can then easily be used for REIMS-based 
analysis as introduced by Balog et al. 
Remaining questions are, whether a feasible cut-off value of tumor cell concentration 
can be defined at the tumor margins of diffusely infiltrating tumors and whether 
REIMS-guided tumor resection results in improved survival. Since tumor cells in 
highly malignant brain tumor such as glioblastoma can be found centimeters away 
from the main core of the lesion, it is virtually impossible to resect the entire tumor 
cell population. Therefore, a reasonable cut-off level of tumor-load at the tumor 
margin as detected by REIMS has to be defined – a trade-off between maximal 
resection and preservation of healthy brain parenchyma.  
Nevertheless, this new technology could be a milestone in brain tumor surgery. We 
are looking forward to see the first results of wide-spread clinical use. 
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